Osteosarcoma • Long non-coding RNA urothelial carcinoma associated 1 • microRNA-182 • Tissue inhibitor of metallapeptidase 2 • PI3K/AKT/GSK3β pathway • NF-κB pathway Abstract Background/Aims: Previous studies demonstrated the oncogenic roles of lncRNA UCA1 in osteosarcoma. This study aimed to explore the internal molecular mechanism of UCA1 on promoting osteosarcoma cell proliferation, migration and invasion. Methods: qRT-PCR was conducted to measure the expression levels of UCA1, miR-182 and TIMP2. Cell transfection was used to change the expression levels of UCA1, miR-182 and TIMP2. Cell viability, migration, invasion and apoptosis were measured using CCK-8 assay, two-chamber migration (invasion) assay and Guava Nexin assay, respectively. The associations between UCA1, miR-182 and iASPP were analyzed by dual luciferase activity assay. The protein expression levels of key factors involved in cell apoptosis, PI3K/AKT/GSK3β pathway and NF-κB pathway, as well as p53, Rb, RECQ family and iASPP were evaluated by western blotting. Results: UCA1 was highly expressed in osteosarcoma MG63 and OS-732 cells. Knockdown of UCA1 inhibited OS-732 cell viability, migration and invasion, but promoted cell apoptosis. miR-182 was up-regulated in OS-732 cells after UCA1 knockdown and participated in the effects of UCA1 on OS-732 cells. TIMP2 was downstream factor of miR-182 and involved in the regulatory roles of miR-182 on OS-732 cell viability, migration, invasion, apoptosis, as well as PI3K/AKT/GSK3β and NF-κB pathways. UCA1 knockdown up-regulated p53, Rb and RECQL5 levels in OS-732 cells, while down-regulated the expression of iASPP. TGF-β or TNF-α treatment could enhance the expression of UCA1 in OS-732 cells. Conclusion: Our research verified that UCA1 exerted oncogenic roles in osteosarcoma cells by regulating miR-182 and TIMP2, as well as PI3K/AKT/ GSK3β and NF-κB pathways.
Introduction
Cancer is a major health problem second only to cardiovascular disease all over the world [1] . Osteosarcoma, characterized by uncontrolled proliferation and invasion of bone-forming mesenchymal cells, has become the most common malignant bone tumor in children, adolescents and older adults [2, 3] . For many osteosarcoma patients, removal of primary tumor is curative [4] . However, if metastasis lesions exist and are not sensitive to treatment, survival of patients will be limited [4] . The 5-year survival rate of non-metastasis patients is 60-70%, while the 5-year survival rate of metastasis patients is only 10-30% [5] . Increasing numbers of reports provide evidences that multiple factors contribute to the growth and metastasis of osteosarcoma [6, 7] . Therefore, it is worth believing that a more clear understanding of osteosarcoma cell proliferation, migration and invasion will be helpful for osteosarcoma treatment.
Long non-coding RNAs (lncRNAs) are recently discovered RNA transcripts in eukaryotic cells with more than 200 nucleotides (nt) in length [8] . As non-coding RNA molecules in cells, lncRNAs participate in the regulation of multiple cell functions, such as cell proliferation, cell differentiation, cell migration and cell apoptosis [9] . Moreover, studies also demonstrate that lncRNAs play critical regulatory roles in a variety of disease processes, including neuro-degeneration and carcinogenesis [10, 11] LncRNA urothelial carcinoma associated 1 (UCA1) has been aroused more and more attention in recent years due to its oncogenic/ tumor-suppressive roles in numerous cancer cells [12, 13] . In terms of osteosarcoma, Li et al. reported that overexpression of UCA1 promoted osteosarcoma initiation and progression [5] . Wen et al. demonstrated that UCA1 was highly expressed in osteosarcoma tissues compared to normal bone tissues and could be as a specific biomarker for diagnosis and prognosis of osteosarcoma [14] . More experimental researches are still needed to further explore the internal molecular mechanism of UCA1 on promoting osteosarcoma growth and metastasis.
MicroRNAs (miRNAs) are another type of non-coding RNA transcripts in eukaryotic cells with 20-24 nucleotides (nt) in length [15] . Similarly to lncRNAs, miRNAs also participate in the regulation of multiple cell functions by altering the expression levels of a variety of genes [16] . LncRNAs can exert oncogenic/tumor-suppressive roles in cancer cells by modulating the expression levels of miRNAs [17] . miRNA-182 (miR-182) is down-regulated in osteosarcoma tissues and plays tumor suppressive roles in osteosarcoma cells [18] . He et al. proved that UCA1 interacted with miR-182 to regulate glioma proliferation and migration by targeting inhibitor of apoptosis-stimulating protein of p53 (iASPP) [19] . However, there is no any information available about the interaction between UCA1 and miR-182 in osteosarcoma cells.
Therefore, in the present study, we further analyzed the effects of UCA1 on osteosarcoma cell proliferation, migration, invasion and apoptosis, as well as miR-182 expression. The possible internal molecular mechanism and signaling pathways, as well as the regulation of UCA1 in osteosarcoma cells were also explored. These findings will provide evidences for further understanding the oncogenic roles of UCA1 in osteosarcoma cells. USA) and 1% (v/v) penicillin-streptomycin-glutamine solution (100X, Gibco, Life Technologies, Carlsbad, CA, USA). Cultures were maintained in a humidity incubator (Sanyo, Jencons, United Kingdom) at 37°C with 5% CO 2 .
Transforming growth factor β (TGF-β) and tumor necrosis factor α (TNF-α) were both purchased from R&D Systems (Minneapolis, MN, USA). TGF-β was dissolved into 10 mM citric acid to a concentration of 0.5 mg/ml. TNF-α was dissolved into distilled water to a concentration of 0.2 mg/ml.
Quantitative reverse transcription PCR (qRT-PCR)
After relevant treatment or transfection, total RNAs in hFOB1.19, MG63 or OS-732 cells were isolated using Trizol TM Plus RNA Purfication kit (Invitrogen, Carlsbad, CA, USA). Then, cDNA was transcribed using Maxima TM H Minus cDNA Synthesis Master Mix (Thermo Fisher Scientific, Waltham, MA, USA). The expression level of UCA1 was measured using TaqMan® Non-coding RNA Assay (Applied Biosystems, Foster City, CA, USA). The expression levels of miR-182, miR183, miR-133b, miR-199a-3p, miR-124, miR-646, miR-100, miR-214, miR-135b, miR-144, miR-18a, miR-1271 and U6 were assessed using mirVana TM qRT-PCR miRNA Detection kit (Invitrogen, Carlsbad, CA, USA). The expression levels of tissue inhibitor of metallapeptidase 2 (TIMP2), p53, Retinoblastoma (Rb), RecQ protein-like 5 (RECQL5), inhibitor of apoptosis-stimulating protein of p53 (iASPP) and GAPDH were detected using Power SYBR-Green Master Mix (Applied Biosystems, Foster City, CA, USA). U6 and GAPDH were acted as endogenous controls, respectively. Data was calculated using 2 -△△Ct method [20] .
Cell transfection
Short-hairpin RNA directed against UCA1 was ligated into U6/GFP/Neo plasmid (GenePharma, Shanghai, China) and referred as sh-UCA1. Empty U6/GFP/Neo plasmid was acted as negative control (NC) and referred as sh-NC. miR-182 mimic, miR-182 inhibitor and their respectively negative control (Scramble, NC) were designed and synthesized by Life Technologies Corporation (Carlsbad, CA, USA). Fulllength TIMP2 sequences was constructed into pEX-2 plasmid (GenePharma, Shanghai, China) and referred as pEX-TIMP2. Empty pEX-2 plasmid was acted as NC and referred as pEX. Cell transfection was conducted using Lipofectamine 3000 reagent (Life Technologies Corporation, MD, USA). Transfection efficiencies were evaluated using qRT-PCR.
Cell viability assay
Cell viability was detected using cell counting kit-8 (CCK-8) assay after sh-UCA1 and/or miR-182 inhibitor or pEX-TIMP2 transfection. Briefly, transfected or non-transfected OS-732 cells were seeded into 96-well plate (Thermo Fisher Scientific, Waltham, MA, USA) with 1 × 10 4 cells per well and cultured at 37°C for 24 h. Then, CCK-8 solution (10 μl) was added into the each well of the plate and the plate was maintained at 37°C for another 1 h. After that, the absorbance of each well at 450 nm was recorded using Micro-plate reader (Bio-Tek Instruments, Winooski, VT, USA). Cell viability was calculated using average absorbance of transfected group/absorbance of non-transfected (control) group × 100%.
Cell migration and invasion assay
Cell migration was assessed using two-chamber migration assay (Corning Incorporated, New York, NY, USA) after sh-UCA1 and/or miR-182 inhibitor or pEX-TIMP2 transfection. Briefly, 1 × 10 3 transfected or nontransfected OS-732 cells were suspended in 200 μl of serum-free DMEM and added into the upper chamber. Complete DMEM (600 μl) was added into the lower chamber. After incubation at 37°C for 48 h, cells were fixed with 4% paraformaldehyde (Beyotime Biotechnology, Shanghai, China). Non-traversed cells in upper chamber were removed using a cotton swab carefully and traversed cells in lower chamber were counted under microscope (Nikon, Japan). Cell migration (%) was calculated using traversed cells in transfected group/traversed cells in non-transfected (control) group × 100%.
Cell invasion was determined using two-chamber invasion assay (Corning Incorporated, New York, NY, USA) after sh-UCA1 and/or miR-182 inhibitor or pEX-TIMP2 transfection, which similarly with the two-chamber migration assay except that the transwell membranes were pre-coated using Matrigel (BD Bioscience, Franklin Lakes, NJ, USA). Cell apoptosis assay Cell apoptosis was evaluated using Guava Nexin assay (Guava Technologies, Hayward, CA, USA) after sh-UCA1 and/or miR-182 inhibitor or pEX-TIMP2 transfection. Briefly, transfected or non-transfected OS-732 cells were seeded into 24-well plate (Thermo Fisher Scientific, Waltham, MA, USA) with 3 × 10 4 cells per well and cultured at 37°C for 24 h. Then, cells in each group were collected and disposed as following step: washed with phosphate buffered saline (PBS) for twice, stained using Nexin solution for 30 min at room temperature in the dark and subjected to flow cytometry analysis using Guava EasyCyte flow cytometer (Guava Technologies, Hayward, CA, USA). Data was quantified using FlowJo software (Tree Star Incorporation, Ashland, OR, USA).
Dual luciferase activity assay
The fragment of UCA1 and the 3'-untranslated regions (3'UTR) fragment of iASPP containing the predicted miR-182 binding sites were amplified by PCR and respectively cloned into pmirGlO Dualluciferase miRNA Target Expression Vector (Promega, Madison, WI, USA) to form reporter vector UCA1-wide-type (UCA1-WT) and iASPP-wide type (iASPP-WT), respectively. To mutate the putative binding sites of miR-182 in UCA1 and 3'UTR of iASPP, the sequence of putative binding sites were replaced and named as UCA1-mutated-type (UCA1-MUT) and iASPP-mutated-type (iASPP-MUT), respectively. Subsequently, the reporter vectors and miR-182 mimic were co-transfected into HEK293 cells as experiment design. DualLuciferase Reporter Assay System (Promega, Madison, WI, USA) was conducted to measure the relative luciferase activities.
Western blotting
After different treatment or transfection, total proteins in OS-732 cells were isolated using PIPA lysis buffer (Beyotime Biotechnology, Shanghai, China) supplemented with phenylmethanesulfony fluoride (PMSF, Beyotime Biotechnology, Shanghai, China). Then, the proteins were quantified using Pierce TM BCA Protein Assay kit (Thermo Fisher Scientific, Waltham, MA, USA). Western blotting system was established as previously described [21] . Equal concentrations of proteins were electrophoresed in polyacrylamide gels and transferred onto nitrocellulose (NC) membranes (Millipore, Bedford, MA, USA). All primary antibodies were pre-prepared in 1% bovine serum albumin (BSA, Solarbio, Beijing, China) solution at a dilution of 1:1000. Anti-Bcl-2 antibody (ab59348), Anti-Bax antibody (ab53154), Anti-Pro-caspase 3 antibody (ab205733), Anti-Cleaved-caspase 3 antibody (ab32042), Anti-Pro-caspase 9 antibody (ab135544), Anti-Cleavedcaspase 9 antibody (ab2324), Anti-TIMP2 antibody (ab180630), Anti-phosphatidylinositol 3-kinase (PI3K) antibody (ab86714), Anti-p-PI3K antibody (ab138364), Anti-protein kinase 3 (AKT) antibody (ab8805), Anti-p-AKT antibody (ab38449), Anti-glycogen synthase kinase-3β (GSK3β) antibody (ab32391), Anti-p-GSK3β antibody (ab75745), Anti-p-inhibitor of nuclear factor kappa B (NF-κB) (IκBα) antibody (ab133462), Anti-t-IκBα antibody (ab7217), Anti-p-p65 antibody (ab86299), Anti-t-p65 antibody (ab16502), Anti-p53 antibody (ab131442), Anti-Rb antibody (ab226979), Anti-RECQL5 antibody (ab91422), Anti-iASPP antibody (ab34898) and anti-GAPDH antibody (ab8245) were all purchased from Abcam Biotechnology (Cambridge, MA, USA). After incubation with primary antibodies at 4°C overnight, the NC membranes were washed with Tris-Buffered Saline and Tween (TBST, Solarbio, Beijing, China) for twice and incubated with Goat AntiRabbit (or Anti-Mouse) IgG H&L (HRP) secondary antibodies (ab205718, ab205719, Abcam Biotechnology, Cambridge, MA, USA) for 1.5 h at room temperature. Signals of proteins were recorded using Bio-Rad ChemiDoc TM XRS system (Bio-Rad Laboratories, Hercules, CA, USA), supplemented with 200 μl Immobilon Western Chemiluminescent HRP Substrate (Millipore, Bedford, MA, USA) on the surface of membranes.
Statistical analysis
All experiments were repeated at least three times in this research. The results of multiple experiments were presented as the mean ± standard deviation (SD). Statistical analysis was performed using Graphpad 6.0 software (Graphpad, San Diego, CA, USA) and P-value was calculated using one-way analysis of variance (ANOVA). Statistical significance was established at P < 0.05. 
Results

UCA1 was highly expressed in osteosarcoma MG63 and OS-732 cells
We first detected the expression levels of UCA1 in human osteoblast hFOB1.19 cells and human osteosarcoma MG63 and OS-732 cells. The results of qRT-PCR showed that compared to hFOB1.19 cells, UCA1 was highly expressed in MG63 and OS-732 cells ( Fig. 1 , P < 0.05 or P < 0.01). This finding implied that UCA1 might be involved in the carcinogenesis of human osteosarcoma cells. Considering that OS-732 cells had a higher expression of UCA1 than MG63 cells, OS-732 cells were chosen for subsequent experiments.
Knockdown of UCA1 inhibited osteosarcoma OS-732 cell viability, migration and invasion, but promoted cell apoptosis
Next, we explored the influence of UCA1 knockdown on OS-732 cell viability, migration, invasion and apoptosis by transfecting sh-UCA1. Fig. 2A presented that sh-UCA1 transfection remarkably decreased the expression level of UCA1 in OS-732 cells (P < 0.01). Fig. 2B displayed that sh-UCA1 transfection significantly reduced the viability of OS-732 cells (P < 0.01). Similar results were found in Fig. 2C and 2D, which illustrated the migration and invasion of OS-732 cells were also decreased after UCA1 knockdown (P < 0.01). Besides, the results 2. Knockdown of UCA1 inhibited osteosarcoma OS-732 cell viability, migration and invasion, but promoted cell apoptosis. After sh-UCA1 transfection, (A) the expression of UCA1 in OS-732 cells, (B-E) the viability, migration, invasion and apoptosis of OS-732 cells, and (F) the expression levels of Bcl-2, Bax, Pro-caspase 3, Cleaved-caspase 3, Pro-caspase 9 and Cleaved-caspase 9 in OS-732 cells were detected using quantitative reverse transcription PCR (qRT-PCR), cell counting kit-8 (CCK-8) assay, two-chamber migration assay, two-chamber invasion assay, Guava Nexin assay and western blotting, respectively. UCA1: Long non-coding RNA urothelial carcinoma associated 1; NC: Negative control; sh: Shorthairpin. *P<0.05, **P<0.01. [18] . Ram et al. reported that miR-183, miR-133b, miR199a-3p, miR-124, miR-646 and miR-100 exerted tumor suppressive roles, as well as miR-214 and miR-135b exerted oncogenic roles in osteosarcoma tissues or cells [22] . Therefore, in this research, we assessed the expression levels of miR-182, miR-183, miR-133b, miR-199a-3p, miR-124, miR-646, miR-100, miR-214 and miR-135b in OS-732 cells after UCA1 knockdown. As displayed in Fig. 3A , sh-UCA1 transfection notably up-regulated the expression levels of miR-182, miR-183, miR-133b, miR-199a-3p, miR-124, miR-646 and miR-100 in OS-732 cells (P < 0.05 or P < 0.01), but had no significant effects on miR-124 and miR-135b expression levels. Previous studies demonstrated that miR-144, miR-18a and miR-1271 were associated with UCA1 [23] [24] [25] . So, we also detected the expression levels of miR-144, miR-18a and miR-1271 in OS-732 cells after UCA1 knockdown. Fig. 3B showed that UCA1 knockdown enhanced the expression levels of miR-182, miR-144 and miR-18a in OS-732 cells (P < 0.01), but had no significant effect on miR-1271 expression level. Compared to miR-144 and miR-18a, miR-182 had a higher expression level after UCA1 knockdown. The result of Fig. 3C displayed that the relative luciferase activity was decreased after co-transfection with miR-182 mimic and UCA1-WT (P < 0.05). These above results suggested that UCA1 could regulate the expression levels of a number of miRNAs that played tumor suppressive roles in OS-732 cells and implied that miR-182 might participate in the effects of UCA1 on OS-732 cell viability, migration, invasion and apoptosis. 
miR-182 participated in the effects of UCA1 on OS-732 cell viability, migration, invasion and apoptosis.
To confirm the regulatory roles of miR-182 in UCA1 knockdown-induced OS-732 cell viability, migration and invasion inhibition, as well as apoptosis, miR-182 inhibitor was transfected into OS-732 cells. Fig. 4A presented that miR-182 inhibitor transfection notably alleviated the sh-UCA1 transfection-induced OS-732 cell viability inhibition (P < 0.05). Similar results were found in Fig. 4B and 4C , which illustrated that compared to sh-UCA1+NC group, the migration and invasion of OS-732 cells were both enhanced in sh-UCA1+miR-182 inhibitor group (P < 0.05). Besides, the results of Fig. 4D pointed out that miR-182 inhibitor transfection reversed the sh-UCA1 transfection-induced OS-732 cell apoptosis (P < 0.05). Western blotting showed that compared to sh-UCA1+NC transfection, sh-UCA1+miR-182 inhibitor transfection decreased the expression levels of Bax, Cleaved-caspase 3 and Cleavedcaspase 9, as well as increased the expression level of Bcl-2 in OS-732 cells (Fig. 4E) . These aforementioned results suggested that miR-182 participated in the effects of UCA1 on OS-732 cell viability, migration, invasion and apoptosis.
The regulatory effects of UCA1 and miR-182 on TIMP2 expression in OS-732 cells.
Then, we tested the effects of UCA1 and miR-182 on TIMP2 expression in OS-732 cells by qRT-PCR and western blotting. As presented in Fig. 5A and 5B, sh-UCA1 transfection up-regulated the mRNA and protein expression levels of TIMP2 in OS-732 cells (P < 0.01 in mRNA level). Fig. 5C showed that miR-182 mimic transfection significantly enhanced the mRNA expression level of TIMP2 in OS-732 cells (P < 0.01), while miR-182 inhibitor transfection remarkably reduced the mRNA expression level of TIMP2 in OS-732 cells (P < 0.05). Similar results were found in Fig. 5D , which displayed that the protein expression level of TIMP2 was also increased after miR-182 mimic transfection and decreased after miR-182 inhibitor transfection. These findings implied that TIMP2 might be a downstream factor of UCA1 and miR-182 and involved in the regulatory effects of UCA1 and miR-182 on OS-732 cell viability, migration, invasion and apoptosis. Fig. 4 . miR-182 participated in the effects of UCA1 on OS-732 cell viability, migration, invasion and apoptosis. After sh-UCA1 and/or miR-182 inhibitor transfection, (A-D) the viability, migration, invasion and apoptosis of OS-732 cells, and (E) the expression levels of Bcl-2, Bax, Pro-caspase 3, Cleaved-caspase 3, Pro-caspase 9 and Cleaved-caspase 9 in OS-732 cells were assessed using cell counting kit-8 (CCK-8) assay, two-chamber migration assay, two-chamber invasion assay, Guava Nexin assay and western blotting, respectively. UCA1: Long non-coding RNA urothelial carcinoma associated 1; miR-182: MicroRNA-182; NC: Negative control; sh: Short-hairpin. *P<0.05, **P<0.01. 
Overexpression of TIMP2 inhibited OS-732 cell viability, migration and invasion, but promoted cell apoptosis
To analyze the roles of TIMP2 in miR-182 inhibitor-induced OS-732 cell viability, migration and invasion increases, as well as cell apoptosis decrease, pEX-TIMP2 was transfected into OS-732 cells. Fig. 6A showed that pEX-TIMP2 transfection dramatically reversed the miR-182 inhibitor-induced TIMP2 expression decrease (P < 0.01). Fig. 6B-6D displayed that pEX-TIMP2 transfection remarkably reversed the miR-182 inhibitor-induced OS-732 cell viability, migration and invasion enhancement (P < 0.05). The results of Fig.  6E presented that pEX-TIMP2 transfection noticeably attenuated the miR-182 inhibitorinduced OS-732 cell apoptosis (P < 0.05). Western blotting showed that compared to miR-182 inhibitor+pEX transfection, the expression levels of Bax, Cleaved-caspase 3 and Cleavedcaspase 9 in OS-732 cells were enhanced, as well as the expression level of Bcl-2 was reduced, 
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry after miR-182 inhibitor+pEX-TIMP2 transfection (Fig. 6F) . These aforementioned results suggested that TIMP2 exerted tumor inhibitory roles in OS-732 cells and participated in the regulatory effects of miR-182 on OS-732 cell viability, migration, invasion and apoptosis.
UCA1 knockdown inactivated PI3K/AKT/GSK3β and NF-κB pathways in OS-732 cells via regulating miR-182 and TIMP2 expression
After that, we investigated the effects of UCA1, miR-182 and TIMP2 on PI3K/AKT/ GSK3β and NF-κB signaling pathways in OS-732 cells. As shown in Fig. 7A and 7B, sh-UCA1 transfection reduced the expression levels of p-PI3K, p-AKT, p-GSK3β, p-IκBα and p-p65 in OS-732 cells, which suggested that UCA1 knockdown could inactivate PI3K/AKT/GSK3β and NF-κB signaling pathways in OS-732 cells. Fig. 7C and 7D presented that miR-182 mimic transfection down-regulated the expression levels of p-PI3K, p-AKT, p-GSK3β, p-IκBα and p-p65 in OS-732 cells, while miR-182 inhibitor had opposite effects. More importantly, pEX-TIMP2 transfection alleviated the effects of miR-182 inhibitor and decreased the expression levels of p-PI3K, p-AKT, p-GSK3β, p-IκBα and p-p65 in OS-732 cells. These findings implied that UCA1 knockdown inactivated PI3K/AKT/GSK3β and NF-κB pathways in OS-732 cells might by influencing miR-182 and TIMP2 expression.
The effects of UCA1 and miR-182 on p53, Rb, RECQL5 and iASPP expression in OS-732 cells
The critical regulatory roles of p53, Rb, iASPP and RECQL family in osteosarcoma cell viability, migration, invasion and apoptosis have been proved in previous researches [26] [27] [28] . In the current study, we measured the mRNA and protein expression levels of p53, Rb, RECQL5 and iASPP in OS-732 cells after UCA1 knockdown. Results in Fig. 8A and 8B presented that sh-UCA1 transfection enhanced the mRNA and protein expression levels of p53, Rb and RECQL5 in OS-732 cells, but reduced the mRNA and protein expression level of iASPP (P < 0.01 in mRNA level). Fig. 8C showed that the relative luciferase activity was reduced after co-transfection with miR-182 mimic and iASPP-WT (P < 0.05). Fig. 8D displayed that miR-182 mimic transfection down-regulated the protein level of iASPP, while miR-182 inhibitor transfection up-regulated the protein level of iASPP in OS-732 cells. These above findings indicated that UCA1 also could modulate a series of tumor suppressive genes or oncogenes in osteosarcoma and suggested that miR-182 negatively regulated the expression of iASPP in OS-732 cells by binding to the 3'UTR of iASPP. (B and C) After TGF-β treatment and/or sh-UCA1 transfection, the expression levels of PI3K, p-PI3K, AKT, p-AKT, GSK3β, p-GSK3β, p-IκBα, t-IκBα, p-p65 and t-p65 in OS-732 cells were evaluated using western blotting. (D and E) After TNF-α treatment and/or sh-UCA1 transfection, the expression levels of PI3K, p-PI3K, AKT, p-AKT, GSK3β, p-GSK3β, p-IκBα, t-IκBα, p-p65 and t-p65 in OS-732 cells were evaluated using western blotting. TGF-β: Transforming growth factor β; TNF-α: Tumor necrosis factor α; UCA1: Long non-coding RNA urothelial carcinoma associated 1; NC: Negative control; sh: Short-hairpin; PI3K: Phosphatidylinositol 3-kinase; AKT: Protein kinase 3; GSK3β: Glycogen synthase kinase-3β; NF-κB: Nuclear factor kappa B; IκBα: Inhibitor of NF-κB. **P<0.01. The expression of UCA1 in OS-732 cells was regulated by TGF-β or TNF-α Finally, we assessed the effects of TGF-β or TNF-α treatment on UCA1 expression in OS-732 cells. Fig. 9A showed that TGF-β or TNF-α treatment both up-regulated the expression level of UCA1 in OS-732 cells (P < 0.01). The results of Fig. 9B and 9C displayed that TGF-β treatment activated PI3K/AKT/GSK3β and NF-κB signaling pathways in OS-732 cells via enhancing the expression levels of p-PI3K, p-AKT, p-GSK3β, p-IκBα and p-p65. sh-UCA1 transfection alleviated the TGF-β treatment-induced activation of PI3K/AKT/GSK3β and NF-κB signaling pathways in OS-732 cells via reducing the expression levels of p-PI3K, p-AKT, p-GSK3β, p-IκBα and p-p65. Similar results were found in Fig. 9D and 9E , which presented that TNF-α treatment also activated PI3K/AKT/GSK3β and NF-κB signaling pathways through enhancing p-PI3K, p-AKT, p-GSK3β, p-IκBα and p-p65 expression levels. sh-UCA1 transfection attenuated the TNF-α treatment-induced activation of PI3K/AKT/GSK3β and NF-κB signaling pathways through reducing p-PI3K, p-AKT, p-GSK3β, p-IκBα and p-p65 expression levels. These findings suggested that TGF-β and TNF-α could modulate the expression of UCA1 in OS-732 cells and activated PI3K/AKT/GSK3β and NF-κB signaling pathways.
Discussion
Osteosarcoma is the most common malignant bone tumor in children, adolescents and older adults with recurrence and metastasis potential [29] . In this research, we confirmed the oncogenic roles of UCA1 in osteosarcoma MG63 and OS-732 cells. We found that the expression levels of UCA1 were obviously increased in osteosarcoma MG63 and OS-732 cells, compared to osteoblast hFOB1.19 cells. Knockdown of UCA1 significantly inhibited OS-732 cell viability, migration and invasion, promoted cell apoptosis, and up-regulated miR-182 expression. Further results indicated that miR-182 participated in the effects of UCA1 on OS-732 cell viability, migration, invasion and apoptosis by modulating TIMP2 expression and PI3K/AKT/GSK3β and NF-κB signaling pathways. In addition, we revealed that UCA1 knockdown up-regulated the expression levels of p53, Rb and RECQL5 in OS-732 cells, while down-regulated the expression level of iASPP. TGF-β or TNF-α could enhance the expression of UCA1 in OS-732 cells.
Abnormal lncRNAs or miRNAs expression and their associations with occurrence of multiple cancers have been studied in a variety of cancer cells [30] [31] [32] . Previous researches have been demonstrated the oncogenic roles of UCA1 in osteosarcoma [14, 33] . In consistent with the previous studies, we also found that UCA1 had high expression levels in osteosarcoma MG63 and OS-732 cells and exerted critical regulatory effects on OS-732 cell viability, migration, invasion and apoptosis in this research. miRNAs play pivotal roles in oncogenic/tumor-suppressive functions of lncRNAs in cancer cells [17, 34] . miR-182, miR-183, miR-133b, miR-199a-3p, miR-124, miR-646 and miR-100 have been found to exert tumor suppressive roles in osteosarcoma tissues and cells [18, 22, 35] . miR-214 and miR13b have been found to exert oncogenic roles in osteosarcoma tissues or cells [22] . Li et al. reported that UCA1 promoted the proliferation and metastasis of human lung tumor cells via regulating miR-144 [23] . Zhu et al. proved that UCA1 desensitized breast cancer cells to trastuzumab through impeding miR-18a expression [24] . Barbagallo et al. indicated that UCA1 was up-regulated in colon rectal cancer and controlled the expression of miR-1271 [25] . In the present study, we found that knockdown of UCA1 significantly increased the expression of miR-182 miR-183, miR-133b, miR-199a-3p, miR-124, miR-646, miR-100, miR-144 and miR-18a in OS-732 cells, but had no significant effects on miR-124, miR-135b and miR-1271 expression levels. These results suggested that UCA1 could regulate the expression levels of a number of miRNAs that played tumor suppressive roles in OS-732 cells. Furthermore, the relative luciferase activity was decreased after co-transfection with miR-182 mimic and UCA1-WT. Suppression of miR-182 obviously alleviated the UCA1 knockdown-induced OS-732 cell viability, migration and invasion inhibition, as well as apoptosis enhancement. [38] . The experimental study from Lu et al. demonstrated that miR-221 promoted renal carcinoma cell proliferation, migration and invasion by modulating TIMP2 expression [39] . In this study, we found that the mRNA and protein expressions of TIMP2 were both enhanced after UCA1 knockdown or miR-182 overexpression and reduced after miR-182 suppression. Further results pointed out that overexpression of TIMP2 remarkably reversed the miR-182 suppression-induced OS-732 cell viability, migration and invasion increases, as well as apoptosis decrease. These results suggested that TIMP2 exerted tumor inhibitory roles in OS-732 cells and participated in the regulatory effects of UCA1 and miR-182 on OS-732 cells. Considering that miR-1271 was also found to regulate the expression of TIMP2 in osteosarcoma cells [40] , we could propose that many miRNAs collectively participated in the regulation of TIMP2 expression in osteosarcoma cells.
It is well known that the activation of PI3K/AKT/GSK3β and NF-κB signaling pathways contribute to the progressions of multiple cancers, including osteosarcoma [41, 42] . miR-375 functions as tumor suppressor in osteosarcoma by inactivating PI3K/AKT/GSK3β signaling pathway [43] . miR-300 inhibits osteosarcoma cell viability and migration through inactivating NF-κB signaling pathway [44] . Therefore, we investigated the effects of UCA1, miR-218 and TIMP2 on PI3K/AKT/GSK3β and NF-κB signaling pathways in OS-732 cells. Results indicated that knockdown of UCA1 inactivated PI3K/AKT/GSK3β and NF-κB signaling pathways in OS-732 cells. Overexpression of miR-182 also inactivated PI3K/AKT/GSK3β and NF-κB signaling pathways in OS-732 cells. Suppression of miR-182 had opposite effects. More importantly, TIMP2 overexpression attenuated the effects of miR-182 suppression on PI3K/AKT/GSK3β and NF-κB signaling pathways. These findings suggested that UCA1 knockdown inactivated PI3K/AKT/GSK3β and NF-κB signaling pathways in OS-732 cells by influencing miR-182 and TIMP2 expression.
Previous studies have reported the critical regulatory roles of p53, Rb, iASPP and RECQL family in osteosarcoma cell growth and metastasis [26] [27] [28] . TGF-β and TNF-α have been demonstrated to play tumor promoting roles in osteosarcoma [45, 46] . So, in the current study, we further assessed the effects of UCA1 on p53, Rb, iASPP and RECQL, as well as the effects of TGF-β and TNF-α on UCA1 in OS-732 cells. We found that sh-UCA1 transfection enhanced the mRNA and protein expression levels of p53, Rb and RECQL5 in OS-732 cells, as well as reduced the mRNA and protein expression level of iASPP. Moreover, miR-182 negatively regulated the expression of iASPP in OS-732 cells. Furthermore, TGF-β and TNF-α treatment enhanced the expression of UCA1 in OS-732 cells and activated PI3K/AKT/GSK3β and NF-κB signaling pathways.
Conclusion
To sum up, our research verified that UCA1 exerted oncogenic roles in osteosarcoma cells by regulating miR-182 and TIMP2, as well as PI3K/AKT/GSK3β and NF-κB signaling pathways. The regulatory network of UCA1 and miR-182 in osteosarcoma cells is very complex, which related to many intercellular and outer-cellular molecules. These findings expand the oncogenic roles of UCA1 in osteosarcoma and provide theoretical basis for deeply exploring the effects of lncRNAs on osteosarcoma diagnosis and treatment.
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